{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:47:42Z","timestamp":1782712062178,"version":"3.54.5"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ring Finger Protein 40 (RNF40), an E3 ubiquitin ligase, plays context-dependent roles in various cancers, serving as either a tumor suppressor or an oncogene. Critically, RNF40 targets LIM domain and actin-binding protein 1 (LIMA1) for degradation via the ubiquitin-proteasome pathway. LIMA1, which is involved in actin cytoskeleton organization, exerts opposing effects in different cancer types. However, the precise functional relationship between RNF40 and LIMA1 in Hepatocellular Carcinoma (HCC) remains poorly understood. Despite the efficacy of immune checkpoint inhibitors, intrinsic resistance affects 40-60% of patients, necessitating novel epigenetic and ubiquitin-related therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study investigated the molecular mechanisms through which RNF40-mediated ubiquitination of LIMA1 influences Hepatocellular Carcinoma (HCC) progression. We utilized an integrative approach combining multi-omics analysis including bulk transcriptomics, single-cell RNA sequencing (scRNA-seq), and spatial transcriptomics with experimental validation using\n                      <jats:italic>in vitro<\/jats:italic>\n                      assays and\n                      <jats:italic>in vivo<\/jats:italic>\n                      mouse models. Differential expression analysis, survival outcome correlation, immune infiltration assessment, and cell-cell communication analyses were performed to characterize the roles of RNF40 and LIMA1 in HCC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      LIMA1 was significantly overexpressed in HCC across multiple transcriptomic and proteomic datasets (log2FC&amp;gt;1.5,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001), and its upregulation correlated with accelerated tumor proliferation, migration, invasion as well as an immunosuppressive checkpoint-enriched TME featured by M2 macrophage infiltration (R\u00a0=\u00a00.498,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001) and CD8+ T cell exclusion. Single-cell and spatial transcriptomic analyses indicated predominant LIMA1 enrichment in malignant cells and tumor lesions. LIMA1 overexpression facilitated HCC clonogenicity, migration, invasion and xenograft tumor growth. Conversely, ectopic RNF40 expression suppressed these malignant phenotypes, and such inhibitory effects were fully abolished upon concurrent LIMA1 overexpression both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      . Re-analysis of TCGA-LIHC revealed that LIMA1 failed to serve as an independent prognostic marker after adjusting for clinicopathological covariates, warranting cautious interpretation of its prognostic implication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings support the biological relevance of a functional RNF40-LIMA1 axis in HCC progression. Together with previously established biochemical evidence of RNF40-mediated LIMA1 ubiquitination and proteasome-dependent degradation, this study provides a rationale for further investigation of the RNF40-LIMA1 axis in HCC. The prognostic and immunotherapy-predictive value of LIMA1 requires validation in independent clinical cohorts and larger ICI-treated HCC datasets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1846606","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:38:43Z","timestamp":1782711523000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics analysis implicates the RNF40-LIMA1 axis in hepatocellular carcinoma progression and immune microenvironment remodeling"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhan","family":"Liu","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Wu","sequence":"additional","affiliation":[{"name":"The Institute of Molecular and Translational Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi\u2019an Jiaotong University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Fan","sequence":"additional","affiliation":[{"name":"The Institute of Molecular and Translational Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi\u2019an Jiaotong University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Liang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saimire","family":"Wushuer","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Song","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cheng","sequence":"additional","affiliation":[{"name":"Beijing Normal University Karamay Affiliated Middle School","place":["Karamay, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqun","family":"Guan","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xinjiang Second Medical College","place":["Karamay, Xinjiang, China"]},{"name":"School of Basic Medical Sciences, Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Institute of Molecular and Translational Medicine, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi\u2019an Jiaotong University","place":["Xi\u2019an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112798","article-title":"Emerging therapies for hepatocellular carcinoma (HCC)","volume":"14","author":"Chakraborty","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00342","article-title":"Structural characteristics, binding partners and related diseases of the calponin homology (CH) domain","volume":"8","author":"Yin","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2016.04.001","article-title":"Unravelling the actin cytoskeleton: A new competitive edge","volume":"26","author":"Davidson","year":"2016","journal-title":"Trends Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-022-00508-4","article-title":"Biochemical and mechanical regulation of actin dynamics","volume":"23","author":"Lappalainen","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.199","article-title":"EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis","volume":"30","author":"Zhang","year":"2011","journal-title":"Oncogene"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710504105","article-title":"EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt","volume":"105","author":"Abe","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202008060","article-title":"Rab40-Cullin5 complex regulates EPLIN and actin cytoskeleton dynamics during cell migration","volume":"220","author":"Linklater","year":"2021","journal-title":"J Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m112.438341","article-title":"Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition","volume":"288","author":"Zhang","year":"2013","journal-title":"J Biol Chem"},{"key":"B13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.juro.2011.03.038","article-title":"EPLIN is a negative regulator of prostate cancer growth and invasion","volume":"186","author":"Sanders","year":"2011","journal-title":"J Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31786","article-title":"Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis","volume":"143","author":"Collins","year":"2018","journal-title":"Int J Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12859-018-2435-4","article-title":"Single sample scoring of molecular phenotypes","volume":"19","author":"Foroutan","year":"2018","journal-title":"BMC Bioinf"},{"key":"B21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: a cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01273-7","article-title":"Spatially informed cell-type deconvolution for spatial transcriptomics","volume":"40","author":"Ma","year":"2022","journal-title":"Nat Biotechnol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-023-01913-6","article-title":"Investigation of GPR143 as a promising novel marker for the progression of skin cutaneous melanoma through bioinformatic analyses and cell experiments","volume":"29","author":"Bai","year":"2024","journal-title":"Apoptosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41420-024-02072-6","article-title":"LIMA1 links the E3 ubiquitin ligase RNF40 to lipid metabolism","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discov"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0689","article-title":"TIP: A web server for resolving tumor immunophenotype profiling","volume":"78","author":"Xu","year":"2018","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1038\/s41598-022-08225-w","article-title":"Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-7-71","article-title":"Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome","volume":"7","author":"Jiang","year":"2008","journal-title":"Mol Cancer"},{"key":"B38","article-title":"Epithelial protein lost in neoplasm (EPLIN) and prostate cancer: lessons learned from the ARCaP model","volume":"9","author":"Wu","year":"2021","journal-title":"Am J Clin Exp Urol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1177\/11795549221109493","article-title":"Overexpression of LIMA1 indicates poor prognosis and promotes epithelial-mesenchymal transition in head and neck squamous cell carcinoma","volume":"16","author":"Ma","year":"2022","journal-title":"Clin Med Insights Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biom11071038","article-title":"Epithelial protein lost in neoplasm, EPLIN, the cellular and molecular prospects in cancers","volume":"11","author":"Zeng","year":"2021","journal-title":"Biomolecules"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2017.03.002","article-title":"Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor","volume":"4","author":"Wu","year":"2017","journal-title":"Genes Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-015-9595-8","article-title":"EPLIN: a fundamental actin regulator in cancer metastasis","volume":"34","author":"Collins","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01556-w","article-title":"Epigenetic modification and a role for the E3 ligase RNF40 in cancer development and metastasis","volume":"40","author":"Fu","year":"2021","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13059-017-1159-5","article-title":"RNF40 regulates gene expression in an epigenetic context-dependent manner","volume":"18","author":"Xie","year":"2017","journal-title":"Genome Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1896","article-title":"Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B","volume":"71","author":"Prenzel","year":"2011","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy165","article-title":"Loss of RNF40 decreases NF-\u03baB activity in colorectal cancer cells and reduces colitis burden in mice","volume":"13","author":"Kosinsky","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mce.2011.11.025","article-title":"Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth","volume":"350","author":"J\u00e4\u00e4skel\u00e4inen","year":"2012","journal-title":"Mol Cell Endocrinol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1846606\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T05:38:44Z","timestamp":1782711524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1846606\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":47,"alternative-id":["10.3389\/fonc.2026.1846606"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1846606","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1846606"}}